Crossmark

Severe proteinuria (but not being on dialysis) may be associated with initial inadequate complement inhibition and delayed hematological response to eculizumab therapy

Crossref DOI link: https://doi.org/10.1007/s40620-023-01831-5

Published Online: 2023-12-22

Published Print: 2024-01-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Allinovi, Marco https://orcid.org/0000-0001-9949-3543
Mazzierli, Tommaso

Caroti, Leonardo

Antognoli, Giulia

Cirami, Calogero Lino
License Information

Version of Record valid from 2023-12-22

Text and Data Mining valid from 2023-12-22

Version of Record valid from 2023-12-22
More Information

Article History

Received: 15 June 2023

Accepted: 10 November 2023

First Online: 22 December 2023

Declarations

:

: On behalf of all authors, the corresponding author states that there is no conflict of interest.

: The study protocol conformed to the Declaration of Helsinki and was approved by a local research ethics committee (study approval number 18217/OSS).

: The present study complies with the guidelines for human studies. This study does not contain any studies with animals.

: Informed consent was obtained from all subjects involved in the study.

Document is current

Any future updates will be listed below